14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 24 Jun 2024

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
R3 14.84 6.00%
R2 14.52 3.72%
R1 14.32 2.31%
Price 14.00
S1 13.69 -2.24%
S2 13.49 -3.65%
S3 13.17 -5.93%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.01 14.32%
R2 15.70 12.14%
R1 14.40 2.86%
Price 14.00
S1 13.48 -3.71%
S2 13.11 -6.36%
S3 12.90 -7.86%

NVAX Predictions History

4 years ago
TradingBelle predicted that NVAX for 2020-05-14 is going $42.11 (3.54%)

Rank:

4 years ago
MHQ predicted that NVAX for 2020-05-14 is going $43.00 (5.73%)

Rank:

4 years ago
MHQ predicted that NVAX for 2020-05-13 is going

Rank:

4 years ago
JS predicted that NVAX for 2020-05-04 is going $16.53 (-8.47%)

4 years ago
Samir Sohail predicted that NVAX for 2020-05-04 is going

Rank:

4 years ago
JS predicted that NVAX for 2020-04-20 is going $19.82 (-16.72%)

4 years ago
Samir Sohail predicted that NVAX for 2020-04-20 is going

Rank:

4 years ago
ericrichardson151343 predicted that NVAX for 2020-04-13 is going

Rank:

4 years ago
2poJeff predicted that NVAX for 2020-04-13 is going $17.11 (0.35%)

4 years ago
JS predicted that NVAX for 2020-04-08 is going $14.21 (-17.29%)

Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT